351 related articles for article (PubMed ID: 18782861)
21. Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor.
Witters L; Scherle P; Friedman S; Fridman J; Caulder E; Newton R; Lipton A
Cancer Res; 2008 Sep; 68(17):7083-9. PubMed ID: 18757423
[TBL] [Abstract][Full Text] [Related]
22. Dimerization of adiponectin receptor 1 is inhibited by adiponectin.
Kosel D; Heiker JT; Juhl C; Wottawah CM; Blüher M; Mörl K; Beck-Sickinger AG
J Cell Sci; 2010 Apr; 123(Pt 8):1320-8. PubMed ID: 20332107
[TBL] [Abstract][Full Text] [Related]
23. The insulin and EGF receptor structures: new insights into ligand-induced receptor activation.
Ward CW; Lawrence MC; Streltsov VA; Adams TE; McKern NM
Trends Biochem Sci; 2007 Mar; 32(3):129-37. PubMed ID: 17280834
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer.
Fridman JS; Caulder E; Hansbury M; Liu X; Yang G; Wang Q; Lo Y; Zhou BB; Pan M; Thomas SM; Grandis JR; Zhuo J; Yao W; Newton RC; Friedman SM; Scherle PA; Vaddi K
Clin Cancer Res; 2007 Mar; 13(6):1892-902. PubMed ID: 17363546
[TBL] [Abstract][Full Text] [Related]
25. Intracellular fate of LDL receptor family members depends on the cooperation between their ligand-binding and EGF domains.
Van Hoof D; Rodenburg KW; Van der Horst DJ
J Cell Sci; 2005 Mar; 118(Pt 6):1309-20. PubMed ID: 15741231
[TBL] [Abstract][Full Text] [Related]
26. Heregulins implicated in cellular functions other than receptor activation.
Breuleux M; Schoumacher F; Rehn D; Küng W; Mueller H; Eppenberger U
Mol Cancer Res; 2006 Jan; 4(1):27-37. PubMed ID: 16446404
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction. RIPping tyrosine kinase receptors apart.
Heldin CH; Ericsson J
Science; 2001 Dec; 294(5549):2111-3. PubMed ID: 11739942
[No Abstract] [Full Text] [Related]
28. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain.
Moriki T; Maruyama H; Maruyama IN
J Mol Biol; 2001 Aug; 311(5):1011-26. PubMed ID: 11531336
[TBL] [Abstract][Full Text] [Related]
29. Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells.
Vidi PA; Chemel BR; Hu CD; Watts VJ
Mol Pharmacol; 2008 Sep; 74(3):544-51. PubMed ID: 18524886
[TBL] [Abstract][Full Text] [Related]
30. Targeting ligand cleavage to inhibit the ErbB pathway in cancer.
Zhou BB
Ann N Y Acad Sci; 2005 Nov; 1059():56-60. PubMed ID: 16382043
[TBL] [Abstract][Full Text] [Related]
31. A dimerization hierarchy in the transmembrane domains of the HER receptor family.
Duneau JP; Vegh AP; Sturgis JN
Biochemistry; 2007 Feb; 46(7):2010-9. PubMed ID: 17253768
[TBL] [Abstract][Full Text] [Related]
32. Structural relationships between the insulin receptor and epidermal growth factor receptor families and other proteins.
Ward CW; Garrett TP
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):630-8. PubMed ID: 15503865
[TBL] [Abstract][Full Text] [Related]
33. Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots.
Kawashima N; Nakayama K; Itoh K; Itoh T; Ishikawa M; Biju V
Chemistry; 2010 Jan; 16(4):1186-92. PubMed ID: 20024999
[TBL] [Abstract][Full Text] [Related]
34. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis.
Wen YH; Koeppen H; Garcia R; Chiriboga L; Tarlow BD; Peters BA; Eigenbrot C; Yee H; Steiner G; Greco MA
Hum Pathol; 2007 Aug; 38(8):1184-91. PubMed ID: 17509661
[TBL] [Abstract][Full Text] [Related]
36. Principles of receptor-based inhibition of erbB family receptor kinases: prospects for new therapies for human cancers.
O'Rourke DM; Zhang X; Greene MI
Proc Assoc Am Physicians; 1997 May; 109(3):209-19. PubMed ID: 9154637
[TBL] [Abstract][Full Text] [Related]
37. Visualization of APP dimerization and APP-Notch2 heterodimerization in living cells using bimolecular fluorescence complementation.
Chen CD; Oh SY; Hinman JD; Abraham CR
J Neurochem; 2006 Apr; 97(1):30-43. PubMed ID: 16515557
[TBL] [Abstract][Full Text] [Related]
38. Spatial control of EGF receptor activation by reversible dimerization on living cells.
Chung I; Akita R; Vandlen R; Toomre D; Schlessinger J; Mellman I
Nature; 2010 Apr; 464(7289):783-7. PubMed ID: 20208517
[TBL] [Abstract][Full Text] [Related]
39. Predominance of activated EGFR higher-order oligomers on the cell surface.
Clayton AH; Orchard SG; Nice EC; Posner RG; Burgess AW
Growth Factors; 2008 Dec; 26(6):316-24. PubMed ID: 18937111
[TBL] [Abstract][Full Text] [Related]
40. Oligomerization-function relationship of EGFR on living cells detected by the coiled-coil labeling and FRET microscopy.
Yamashita H; Yano Y; Kawano K; Matsuzaki K
Biochim Biophys Acta; 2015 Jun; 1848(6):1359-66. PubMed ID: 25771448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
